JVPH.OB Insider Trading Activity and SEC Form 4 Filings
JVPH.OB insider trading summary
No open-market insider purchases or sales of Javelin Pharmaceuticals, Inc (JVPH.OB) have been reported on SEC Form 4 in the past 12 months.
Latest JVPH.OB insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Nov 22, 2005 | Daniel B Carr | Chief Executive Officer | Buy | $6K (2,000 @ $3.10) |
| Nov 22, 2005 | Fred H Mermelstein | President | Buy | $8K (2,500 @ $3.20) |
| Nov 22, 2005 | William P Peters | Director | Buy | $3K (1,000 @ $3.12) |
| Nov 22, 2005 | William P Peters | Director | Buy | $3K (1,000 @ $3.20) |
| Nov 22, 2005 | Peter M Kash | Director | Buy | $32K (10,000 @ $3.20) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.